21:14:21 EDT Sat 22 Mar 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:TDSGF - TELO GENOMICS CORP - https://www.3dsignatures.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TDSGF - Qnot subscribed0.0882    0.1793  0.0541Mar 14Mar 1215 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-03-12 08:31U:TDSGFNews ReleaseTelo Genomics Appoints Baechler Executive Chairman of The Board of Directors
2025-02-27 08:31U:TDSGFNews ReleaseTelo Genomics Announces Expanded Partnership with Trusted Health Advisors
2024-12-12 08:46U:TDSGFNews ReleaseTelo Genomics Announces Private Placement for up to $2 Million
2024-11-19 08:46U:TDSGFNews ReleaseTelo Genomics Receives Approval from the Intellectual Property Ontario Program (IPON)
2024-10-30 08:46U:TDSGFNews ReleaseTelo Genomics Expands its Strategic Collaboration with Mayo Clinic
2024-10-22 08:47U:TDSGFNews ReleaseTelo Genomics Presents New Performance Data for Its Smoldering Myeloma Prognostic Test
2024-09-10 08:46U:TDSGFNews ReleaseTelo Genomics Assessing MRD Status in TELO-DMRD Study
2024-08-13 08:46U:TDSGFNews ReleaseTelo Genomics Receives CLIA Certification
2024-06-18 08:46U:TDSGFNews ReleaseTelo Genomics Announces Its TeloViewSMM Test Is Accepted as Laboratory Developed Test by CAP
2024-06-12 08:46U:TDSGFNews ReleaseTelo Genomics Presents Proprietary Artificial Intelligence Methodologies at ASCO 2024
2024-05-30 08:46U:TDSGFNews ReleaseTelo Genomics Announces Publication of Results from Its Smoldering Myeloma Clinical Study in the American Journal of Hematology
2024-05-15 08:46U:TDSGFNews ReleaseTelo Genomics and Emery Pharma Announce Collaboration
2024-04-10 08:46U:TDSGFNews ReleaseTelo Genomics Receives Accreditation from College of American Pathologists
2024-04-02 08:46U:TDSGFNews ReleaseTelo Genomics' Flagship MRD Clinical Trial Expands into Multi-Center Trial